IDWeek 2013: Vaccines

Girls 9-13 years with HIV who received the quadrivalent human papillomavirus vaccine (qHPV) had significantly lower peak geometric mean titers (GMT) vs. same-aged girls without HIV infection, a study presented at IDWeek 2013 has found.

Investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y elicited similar responses in adolescents to those anticipated from the constituent ACWY and B vaccines, a study presented at IDWeek 2013 has found.

In a cohort of pregnant women, no associations were found between the 2010-2011 seasonal influenza infection or vaccination and four common maternal outcomes—gestational hypertension, preeclampsia/eclampsia, gestational diabetes, and chorioamnionitis—a prospective study concluded at IDWeek 2013.

Three doses of HEPLISAV induced significantly higher seroprotection and antibody concentration than 4 double doses of Engerix-B in a highly immunocompromised population, as presented at IDWeek 2013.

The risk for immune thrombocytopenia purpura (ITP) following administration the measles-mumps-rubella-varicella (MMRV) vaccine or MMR with a separately administered varicella vaccine is consistent with previous studies in children ages 1-2 years, as reported at IDWeek 2013.

The 50:50mcg rAT:rLukS-PV vaccine formulation had a favorable immunogenicity profile, producing neutralizing antibodies through Day 84, according to a study presented at IDWeek 2013.

Influenza vaccination protects against disease in obese as well as non-obese children leading to improved school attendance, results of a study reported at IDWeek 2013.

White women and those of higher socioeconomic status who received an inactivated seasonal influenza vaccine while pregnant had significantly reduced odds of preterm births, while women enrolled in the Women, Infant and Child program and Black women had reduced odds of delivering children small for gestational age, as reported at IDWeek 2013.